- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02386163
Large-scale ex Vivo Expansion and Characterization of Two Kinds of MSC From Knee for Clinical Application
Large-scale ex Vivo Expansion and Characterization of Synovial Membrane MSC (SM-MSC) and Infrapatellar Fat Pad MSC (IF-MSC) for Clinical Application
According to many researches, mesenchymal stem cells (MSC) isolated from synovial membrane and infrapatellar fat pad have higher ex vivo proliferation capacity, multipotency and ability to undergo chondrogenesis.
Based on this concept, the investigators plan to get two removed tissues (synovial membrane and infrapatellar fat pad) from patients who have an operation of TKR (Total Knee Replacement). The investigators are going to isolate and expand MSC from these two tissues respectively, and then compare their characterization and potential for clinical application. In the other hand, the investigators plan to build techniques and procedures which comply with "Good Tissue Practices (GTP)".
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
New Taipei City, Taiwan, 220
- Far Eastern Memorial Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Patient who have an total knee replacement surgery
Exclusion Criteria:
Patient who don't sign the agreement
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Compare MSCs from synovial membrane and infrapatellar fat pad
Time Frame: 2 months
|
Comparison items include doubling time, phenotype, chondrogenesis and biological activity.
|
2 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Chih-Hung Chang, MD, Ph.D, Far Eastern Memorial Hospital
- Study Chair: Shing-Mou Lee, EMO Biomedicine Corp.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EMO-IF-MSC-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Injuries
-
Mayo ClinicCompletedArthroplasty, Replacement, Knee | Injuries, KneeUnited States
-
Wake Forest University Health SciencesTerminatedInjuries, KneeUnited States
-
Poitiers University HospitalWithdrawn
-
Universidad de ZaragozaUnknownAnterior Cruciate Ligament Injuries | Injuries, Knee | Prevention & ControlSpain
-
Tissue Regenix LtdNot yet recruitingMultiligament Knee Injuries
-
Istituto Ortopedico RizzoliNot yet recruitingStiffness of Knee, Not Elsewhere Classified | Knee FracturesItaly
-
Medipol UniversityRecruitingKnee Osteoarthritis | Knee Injuries | Knee Arthritis | Knee DiseaseTurkey
-
Technical University of MunichCompleted
-
University of PittsburghMayo Clinic; University of Missouri-Columbia; Washington University School of... and other collaboratorsRecruitingKnee Dislocations | Multiple Ligament Knee InjuriesUnited States
-
University of PennsylvaniaCompletedSurgery | Opioid Use | Orthopedic Surgery | Neurosurgery | Acute Injuries KneeUnited States
Clinical Trials on MSC from synovial membrane and infrapatellar Fat Pad
-
University of Sao Paulo General HospitalNot yet recruitingKnee Injuries | Cartilage Injury | Cell- and Tissue-Based Therapy
-
Merz Pharmaceuticals GmbHCompleted
-
Merz Pharmaceuticals GmbHCompletedStroke | Cerebral Palsy | Intellectual Disability | Traumatic Brain Injury | Chronic Troublesome SialorrheaGeorgia, Hungary, Poland, Russian Federation, Serbia, Ukraine
-
Merz Pharmaceuticals GmbHCompletedParkinson's Disease | Traumatic Brain Injury | Chronic Troublesome Sialorrhea | Post-strokeGermany, Poland
-
Merz Pharmaceuticals GmbHCompletedLower Limb and Combined Lower Limb and Upper Limb Spasticity Due to Cerebral PalsyPoland, Austria, Czechia, Estonia, Germany, Israel, Korea, Republic of, Romania, Russian Federation, Slovakia, Turkey, Ukraine
-
Merz Pharmaceuticals GmbHCompletedLower Limb Spasticity Due to Cerebral PalsyPoland, Austria, Czechia, Estonia, France, Germany, Israel, Korea, Republic of, Romania, Russian Federation, Slovakia, Spain, Turkey, Ukraine